Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations
-
Brammeld, Jonathan S. (Wellcome Trust Sanger Institute (Regne Unit))
;
Petljak, Mia (Wellcome Trust Sanger Institute (Regne Unit)) ;
Martincorena, Inigo (Wellcome Trust Sanger Institute (Regne Unit)) ;
Williams, Steven P. (Wellcome Trust Sanger Institute (Regne Unit)) ;
García Alonso, Luz (European Molecular Biology Laboratory (Regne Unit)) ;
Dalmases, Alba (Hospital del Mar (Barcelona, Catalunya)) ;
Bellosillo Paricio, Beatriz (Hospital del Mar (Barcelona, Catalunya)) ;
Robles-Espinoza, Carla Daniela (Universidad Nacional Autónoma de México) ;
Price, Stacey (Wellcome Trust Sanger Institute (Regne Unit)) ;
Barthorpe, Syd (Wellcome Trust Sanger Institute (Regne Unit)) ;
Tarpey, Patrick (Wellcome Trust Sanger Institute (Regne Unit)) ;
Alifrangis, Constantine (Wellcome Trust Sanger Institute (Regne Unit)) ;
Bignell, Graham (Wellcome Trust Sanger Institute (Regne Unit)) ;
Vidal, Joana (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Young, Jamie (Wellcome Trust Sanger Institute (Regne Unit)) ;
Stebbings, Lucy (Wellcome Trust Sanger Institute (Regne Unit)) ;
Beal, Kathryn (Wellcome Trust Sanger Institute (Regne Unit)) ;
Stratton, Michael R. (Wellcome Trust Sanger Institute (Regne Unit)) ;
Saez-Rodriguez, Julio (University Hospital Aachen (Alemanya)) ;
Garnett, Mathew (Wellcome Trust Sanger Institute (Regne Unit)) ;
Montagut, Clara (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Iorio, Francesco (European Molecular Biology Laboratory (Regne Unit)) ;
McDermott, Ultan (Wellcome Trust Sanger Institute (Regne Unit)) ;
Universitat Autònoma de Barcelona